Isobel Thomas - Bristows

Isobel joined Bristows in March 2020 as an associate in the competition team.

Since qualifying, she has assisted on merger control and regulatory work in the pharmaceutical sector.

Related Articles

Updated CMA merger guidance as NSI Act comes into force

Illumina/Grail: bio-tech companies in the firing line as the European Commission expands the limits of European merger control

Groupe Canal+ v Commission: CJEU overturns Commission commitments decision with implications for the European film and television industry

View more from Isobel